The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
339 - If we believe content is PAAB exempt, due to new guidelines, do you need to review the content and how it will be used to determine PAAB exemption and then send us a letter stating exemption or not?
-
There is no requirement to submit pieces which fall within the realm of exempt advertising per PAAB code section 1.5 or non-advertising per the Health Canada policy document "The Distinction Between Advertising and Other Activities". If you are uncertain about whether the piece requires review, feel free to use our written opinion service. See the fee schedule on our website
